MD Anderson at Cooper First in the World to Enroll a Patient In a Promising New Clinical Trial for Treatment of Metastatic Melanoma
(CAMDEN, NJ) – Researchers at MD Anderson Cancer Center at Cooper are leading the way in new approaches to treating advanced melanoma using tumor infiltrating lymphocyte (TIL) therapy. Earlier this year, MD…
Read the story